Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-10-23
DOI
10.1002/ijc.32751
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis
- (2019) Divya Thomas et al. Molecular Cancer
- Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology
- (2019) Neel I. Nissen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313
- (2019) Ramesh K. Ramanathan et al. JOURNAL OF CLINICAL ONCOLOGY
- Reshaping the Tumor Stroma for Treatment of Pancreatic Cancer
- (2018) Claire Vennin et al. GASTROENTEROLOGY
- High turnover of extracellular matrix reflected by specific protein fragments measured in serum is associated with poor outcomes in two metastatic breast cancer cohorts
- (2018) Allan Lipton et al. INTERNATIONAL JOURNAL OF CANCER
- HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma
- (2018) Sunil R. Hingorani et al. JOURNAL OF CLINICAL ONCOLOGY
- Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration
- (2018) Willi Sauerbrei et al. JNCI-Journal of the National Cancer Institute
- Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer
- (2018) Noomi Vainer et al. Oncotarget
- Elucidating the link between collagen and pancreatic cancer: what’s next?
- (2018) Shin Hamada et al. Expert Review of Gastroenterology & Hepatology
- Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration
- (2018) Willi Sauerbrei et al. JNCI-Journal of the National Cancer Institute
- Plasma inflammatory cytokines and survival of pancreatic cancer patients
- (2018) A. Babic et al. Clinical and Translational Gastroenterology
- Extracellular matrix (ECM) circulating peptide biomarkers as potential predictors of survival in patients (pts) with untreated metastatic pancreatic ductal adenocarcinoma (mPDA) receiving pegvorhyaluronidase alfa (PEGPH20), nab-paclitaxel (A), and gemcitabine (G).
- (2018) Song Wang et al. JOURNAL OF CLINICAL ONCOLOGY
- Evaluation of the Impact of Preoperative Values of Hyaluronic Acid and Type IV Collagen on the Outcome of Patients with Hepatocellular Carcinoma After Hepatectomy
- (2018) Junji Ueda et al. JOURNAL OF NIPPON MEDICAL SCHOOL
- Non-invasive biomarkers derived from the extracellular matrix associate with response to immune checkpoint blockade (anti-CTLA-4) in metastatic melanoma patients
- (2018) Christina Jensen et al. Journal for ImmunoTherapy of Cancer
- Is hyaluronan deposition in the stroma of pancreatic ductal adenocarcinoma of prognostic significance?
- (2017) Florian Gebauer et al. PLoS One
- Excessive matrix metalloprotease-mediated degradation of interstitial tissue (type I collagen) independently predicts short-term survival in an observational study of postmenopausal women diagnosed with cancer
- (2017) Nicholas Willumsen et al. Oncotarget
- More deaths from pancreatic cancer than breast cancer in the EU by 2017
- (2016) J. Ferlay et al. ACTA ONCOLOGICA
- Mounting Pressure in the Microenvironment: Fluids, Solids, and Cells in Pancreatic Ductal Adenocarcinoma
- (2016) Christopher C. DuFort et al. GASTROENTEROLOGY
- Plasma hyaluronic acid level as a prognostic and monitoring marker of metastatic breast cancer
- (2016) Cike Peng et al. INTERNATIONAL JOURNAL OF CANCER
- Hyaluronic acid in digestive cancers
- (2016) Ruo-Lin Wu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Pancreatic cancer: cause for optimism?
- (2016) The Lancet Oncology LANCET ONCOLOGY
- Highly aligned stromal collagen is a negative prognostic factor following pancreatic ductal adenocarcinoma resection
- (2016) Cole R. Drifka et al. Oncotarget
- Excessive collagen turnover products are released during colorectal cancer progression and elevated in serum from metastatic colorectal cancer patients
- (2016) S. N. Kehlet et al. Scientific Reports
- Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer
- (2015) C. J. Whatcott et al. CLINICAL CANCER RESEARCH
- Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
- (2015) Xiaofeng Zheng et al. NATURE
- Breaching the Castle Walls: Hyaluronan Depletion as a Therapeutic Approach to Cancer Therapy
- (2015) H. Michael Shepard Frontiers in Oncology
- Stromal reengineering to treat pancreas cancer
- (2014) I. M. Stromnes et al. CARCINOGENESIS
- Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy
- (2014) Mara H. Sherman et al. CELL
- Tumor-Associated Hyaluronan Limits Efficacy of Monoclonal Antibody Therapy
- (2014) N. C. Singha et al. MOLECULAR CANCER THERAPEUTICS
- Extracellular matrix specific protein fingerprints measured in serum can separate pancreatic cancer patients from healthy controls
- (2013) Nicholas Willumsen et al. BMC CANCER
- Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer
- (2013) Nicolai A. Schultz et al. PLoS One
- Prognostic Impact of Hyaluronan and Its Regulators in Pancreatic Ductal Adenocarcinoma
- (2013) Xiao-Bo Cheng et al. PLoS One
- Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
- (2012) Paolo P. Provenzano et al. CANCER CELL
- The Pancreas Cancer Microenvironment
- (2012) C. Feig et al. CLINICAL CANCER RESEARCH
- Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
- (2012) Michael A Jacobetz et al. GUT
- Development of a novel metastatic breast cancer score based on hyaluronic acid metabolism
- (2012) Hatem A. El-mezayen et al. MEDICAL ONCOLOGY
- The Desmoplastic Stroma Plays an Essential Role in the Accumulation and Modulation of Infiltrated Immune Cells in Pancreatic Adenocarcinoma
- (2011) Vegard Tjomsland et al. Clinical & Developmental Immunology
- Enzymatic Depletion of Tumor Hyaluronan Induces Antitumor Responses in Preclinical Animal Models
- (2010) C. B. Thompson et al. MOLECULAR CANCER THERAPEUTICS
- Inflammation and pancreatic cancer: an evidence-based review
- (2009) Julia B Greer et al. CURRENT OPINION IN PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now